237 related articles for article (PubMed ID: 36671636)
1. Attenuation of Hyperlipidemia by Medicinal Formulations of
Rachitha P; Krishnaswamy K; Lazar RA; Gupta VK; Inbaraj BS; Raghavendra VB; Sharma M; Sridhar K
Bioengineering (Basel); 2023 Jan; 10(1):. PubMed ID: 36671636
[TBL] [Abstract][Full Text] [Related]
2. Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms.
Variya BC; Bakrania AK; Patel SS
Pharmacol Res; 2016 Sep; 111():180-200. PubMed ID: 27320046
[TBL] [Abstract][Full Text] [Related]
3. Amla (Emblica officinalis Gaertn), a wonder berry in the treatment and prevention of cancer.
Baliga MS; Dsouza JJ
Eur J Cancer Prev; 2011 May; 20(3):225-39. PubMed ID: 21317655
[TBL] [Abstract][Full Text] [Related]
4. Traditional uses, bioactive composition, pharmacology, and toxicology of Phyllanthus emblica fruits: A comprehensive review.
Saini R; Sharma N; Oladeji OS; Sourirajan A; Dev K; Zengin G; El-Shazly M; Kumar V
J Ethnopharmacol; 2022 Jan; 282():114570. PubMed ID: 34480995
[TBL] [Abstract][Full Text] [Related]
5. Phytochemistry, pharmacology and medicinal properties of Phyllanthus emblica Linn.
Gaire BP; Subedi L
Chin J Integr Med; 2014 Dec; ():. PubMed ID: 25491539
[TBL] [Abstract][Full Text] [Related]
6. Hepatoprotective properties of the Indian gooseberry (Emblica officinalis Gaertn): a review.
Thilakchand KR; Mathai RT; Simon P; Ravi RT; Baliga-Rao MP; Baliga MS
Food Funct; 2013 Oct; 4(10):1431-41. PubMed ID: 23978895
[TBL] [Abstract][Full Text] [Related]
7. Insight about the biochemical composition, postharvest processing, therapeutic potential of Indian gooseberry (amla), and its utilization in development of functional foods-A comprehensive review.
Khalid Muzaffar ; Sofi SA; Makroo HA; Darakshan Majid ; Dar BN
J Food Biochem; 2022 Mar; ():e14132. PubMed ID: 35342961
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of Phyllanthus emblica (amla): the ayurvedic wonder.
Krishnaveni M; Mirunalini S
J Basic Clin Physiol Pharmacol; 2010; 21(1):93-105. PubMed ID: 20506691
[TBL] [Abstract][Full Text] [Related]
9. Advances in biotechnology of
Gantait S; Mahanta M; Bera S; Verma SK
3 Biotech; 2021 Feb; 11(2):62. PubMed ID: 33489680
[No Abstract] [Full Text] [Related]
10. Indian Indigenous Fruits as Radioprotective Agents: Past, Present and Future.
Kudva AK; Raghu SV; Rao S; Venkatesh P; Hegde SK; D'souza RK; Baliga-Rao MP; Simon P; Baliga MS
Anticancer Agents Med Chem; 2022; 22(1):53-63. PubMed ID: 34229590
[TBL] [Abstract][Full Text] [Related]
11. Traditional knowledge to clinical trials: A review on therapeutic actions of Emblica officinalis.
Yadav SS; Singh MK; Singh PK; Kumar V
Biomed Pharmacother; 2017 Sep; 93():1292-1302. PubMed ID: 28747010
[TBL] [Abstract][Full Text] [Related]
12. A systematic review on the cardiovascular pharmacology of
Hashem-Dabaghian F; Ziaee M; Ghaffari S; Nabati F; Kianbakht S
J Cardiovasc Thorac Res; 2018; 10(3):118-128. PubMed ID: 30386531
[No Abstract] [Full Text] [Related]
13. Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study.
Kapoor MP; Suzuki K; Derek T; Ozeki M; Okubo T
Contemp Clin Trials Commun; 2020 Mar; 17():100499. PubMed ID: 31890983
[TBL] [Abstract][Full Text] [Related]
14. Influence of Emblica officinalis aqueous extract on growth and antioxidant defense system of human hepatoma cell line (HepG2).
Shivananjappa MM; Joshi MK
Pharm Biol; 2012 Apr; 50(4):497-505. PubMed ID: 22133060
[TBL] [Abstract][Full Text] [Related]
15. Physical and chemical characteristics of different cultivars of Indian gooseberry (
Tewari R; Kumar V; Sharma HK
J Food Sci Technol; 2019 Mar; 56(3):1641-1648. PubMed ID: 30956345
[TBL] [Abstract][Full Text] [Related]
16. Analgesic Effect of Indian Gooseberry (Emblica officinalis Fruit) Extracts on Postoperative and Neuropathic Pain in Rats.
Lim DW; Kim JG; Kim YT
Nutrients; 2016 Nov; 8(12):. PubMed ID: 27898027
[TBL] [Abstract][Full Text] [Related]
17. Supplementation of Emblica officinalis (Amla) extract reduces oxidative stress in uremic patients.
Chen TS; Liou SY; Chang YL
Am J Chin Med; 2009; 37(1):19-25. PubMed ID: 19222108
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia.
Upadya H; Prabhu S; Prasad A; Subramanian D; Gupta S; Goel A
BMC Complement Altern Med; 2019 Jan; 19(1):27. PubMed ID: 30670010
[TBL] [Abstract][Full Text] [Related]
19. A Pilot clinical study to evaluate the effect of Emblica officinalis extract (Amlamax™) on markers of systemic inflammation and dyslipidemia.
Antony B; Benny M; Kaimal TN
Indian J Clin Biochem; 2008 Oct; 23(4):378-81. PubMed ID: 23105791
[TBL] [Abstract][Full Text] [Related]
20. Emblica officinalis and hepatocarcinogenesis: a chemopreventive study in Wistar rats.
Sultana S; Ahmed S; Jahangir T
J Ethnopharmacol; 2008 Jun; 118(1):1-6. PubMed ID: 18467048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
